Antiplatelet Drug Regimen in Patients With Stent Thrombosis - Insights From the PESTO French Optical Coherence Tomography Registry

作者：Amabile Nicolas^*; Cayla Guillaume; Motreff Pascal; Trouillet Charlotte; Range Gregoire; Dubreuil Olivier; Vautrin Estelle; Derimay Francois; Mangin Lionel; Meneveau Nicolas; Caussin Christophe; Souteyrand Geraud

来源：Circulation Journal, 2017, 81(10): 1469-+.

DOI：10.1253/circj.CJ-17-0181

• ST mostly occurs in patients receiving DAPT or SAPT
• Any underlying mechanical abnormality of ST can be involved
• irrespective of the APT regimen

Background: Stent thrombosis (ST) may be triggered by different phenomena, including underlying device abnormalities and modification of the antiplatelet therapy (APT) regimen. This work investigated the characteristics of APT regimens and their relationships with ST mechanisms among a large cohort of patients evaluated by optical coherence tomography (OCT).
Methods and Results: A prospective multicenter registry was screened for patients with confirmed ST. OCT was performed after the initial intervention to the culprit lesion. ST was classified as acute (AST), subacute (SAST), late (LST) and very late (VLST). OCT records were analyzed in a central core laboratory. A total of 120 patients (median age 62 years, 89% male) were included in the study. VLST was the clinical presentation in 75%, LST in 6% and SAST+ AST in 19% of the patients. Single APT (SAPT) was given in 61%, double APT (DAPT) in 27% and no APT in 12% of the cases at the time of the ST. A recent (= 15 days) APT modification was reported in 22% of the patients. An underlying mechanical abnormality was identified by OCT in 96.7% of the cases. Ruptured neoatherosclerotic lesions were significantly more frequent in patients without APT compared with the others.
Conclusions: ST mostly occurs in patients receiving DAPT or SAPT. Any underlying mechanical abnormality of ST can be involved, irrespective of the APT regimen.

• 出版日期2017-10